Notice of Availability of FAQ for RFA-MH-22-110 and RFA-MH-22-111: Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes Consortium
Notice Number:
NOT-MH-22-240

Key Dates

Release Date:

May 9, 2022

Related Announcements

RFA-MH-22-110 - Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes: Data Resource and Administrative Coordination Center (U24 Clinical Trial Not Allowed)

RFA-MH-22-111 - Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes: Assay and Data Generation Centers (RM1 Clinical Trial Not Allowed)

Issued by

National Institute of Mental Health (NIMH)

Purpose

On January 19, 2022, The National Institute of Mental Health (NIMH) issued the Funding Opportunity Announcements (FOAs) RFA-MH-22-110, “Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes: Data Resource and Administrative Coordination Center (U24 Clinical Trial Not Allowed)” and RFA-MH-22-111, " Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes: Assay and Data Generation Centers (RM1 Clinical Trial Not Allowed)”.

To assist potential applicants to the above-referenced FOA, NIMH held a Technical Assistance Webinar on March 15, 2022. This Notice alerts applicants to the availability of subsequent Frequently Asked Questions (FAQ). The FAQ are available on the NIMH website.

Inquiries

Please direct all inquiries to:

Jamie Driscoll
National Institute of Mental Health (NIMH)
Telephone: 301-443-5288
Email: jdrisco1@mail.nih.gov